119 related articles for article (PubMed ID: 1572137)
1. Inoculated mouse model of Pneumocystis carinii infection.
Bartlett MS; Queener SF; Durkin MM; Shaw MA; Smith JW
Diagn Microbiol Infect Dis; 1992 Feb; 15(2):129-34. PubMed ID: 1572137
[TBL] [Abstract][Full Text] [Related]
2. Inoculated mouse model of Pneumocystis carinii pneumonia.
Bartlett MS; Queener SF; Durkin MM; Shaw MM; Smith JW
J Protozool; 1991; 38(6):130S-131S. PubMed ID: 1818136
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of intermittent dosage of 8-aminoquinolines for therapy or prophylaxis of Pneumocystis pneumonia in rats.
Queener SF; Dean RA; Bartlett MS; Milhous WK; Berman JD; Ellis WY; Smith JW
J Infect Dis; 1992 Apr; 165(4):764-8. PubMed ID: 1532406
[TBL] [Abstract][Full Text] [Related]
4. 8-Aminoquinolines from Walter Reed Army Institute for Research for treatment and prophylaxis of Pneumocystis pneumonia in rat models.
Bartlett MS; Queener SF; Tidwell RR; Milhous WK; Berman JD; Ellis WY; Smith JW
Antimicrob Agents Chemother; 1991 Feb; 35(2):277-82. PubMed ID: 2024961
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of clindamycin/primaquine versus trimethoprim/sulfamethoxazole in primary treatment of Pneumocystis carinii pneumonia.
Ruf B; Rohde I; Pohle HD
Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):207-10. PubMed ID: 2060533
[TBL] [Abstract][Full Text] [Related]
6. Pneumocystis carinii: improved models to study efficacy of drugs for treatment or prophylaxis of Pneumocystis pneumonia in the rat (Rattus spp.).
Bartlett MS; Fishman JA; Durkin MM; Queener SF; Smith JW
Exp Parasitol; 1990 Jan; 70(1):100-6. PubMed ID: 2295322
[TBL] [Abstract][Full Text] [Related]
7. Clindamycin/primaquine as prophylaxis for Pneumocystis carinii pneumonia.
Barber BA; Pegram PS; High KP
Clin Infect Dis; 1996 Oct; 23(4):718-22. PubMed ID: 8909833
[TBL] [Abstract][Full Text] [Related]
8. Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model.
Hughes WT; Killmar JT; Oz HS
J Infect Dis; 1994 Oct; 170(4):906-11. PubMed ID: 7930735
[TBL] [Abstract][Full Text] [Related]
9. Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group.
Safrin S; Finkelstein DM; Feinberg J; Frame P; Simpson G; Wu A; Cheung T; Soeiro R; Hojczyk P; Black JR
Ann Intern Med; 1996 May; 124(9):792-802. PubMed ID: 8610948
[TBL] [Abstract][Full Text] [Related]
10. Improved rat model of Pneumocystis carinii pneumonia: induced laboratory infections in Pneumocystis-free animals.
Boylan CJ; Current WL
Infect Immun; 1992 Apr; 60(4):1589-97. PubMed ID: 1548080
[TBL] [Abstract][Full Text] [Related]
11. Comparison of corticosteroid- and L3T4+ antibody-immunosuppressed mouse models of Pneumocystis carinii pneumonia for evaluation of drugs and leukocytes.
Bartlett MS; Current WL; Orazi A; Bauer NL; Neiman RS; Queener SF; Smith JW
Clin Diagn Lab Immunol; 1994 Sep; 1(5):511-6. PubMed ID: 8556494
[TBL] [Abstract][Full Text] [Related]
12. Clindamycin/primaquine versus trimethoprim-sulfamethoxazole as primary therapy for Pneumocystis carinii pneumonia in AIDS: a randomized, double-blind pilot trial.
Toma E; Fournier S; Dumont M; Bolduc P; Deschamps H
Clin Infect Dis; 1993 Aug; 17(2):178-84. PubMed ID: 8399863
[TBL] [Abstract][Full Text] [Related]
13. Clindamycin with primaquine vs. Trimethoprim-sulfamethoxazole therapy for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS: a multicenter, double-blind, randomized trial (CTN 004). CTN-PCP Study Group.
Toma E; Thorne A; Singer J; Raboud J; Lemieux C; Trottier S; Bergeron MG; Tsoukas C; Falutz J; Lalonde R; Gaudreau C; Therrien R
Clin Infect Dis; 1998 Sep; 27(3):524-30. PubMed ID: 9770152
[TBL] [Abstract][Full Text] [Related]
14. Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model.
Brun-Pascaud M; Chau F; Derouin F; Girard PM
J Antimicrob Chemother; 1998 Mar; 41 Suppl B():57-62. PubMed ID: 9579714
[TBL] [Abstract][Full Text] [Related]
15. Albendazole inhibits Pneumocystis carinii proliferation in inoculated immunosuppressed mice.
Bartlett MS; Edlind TD; Lee CH; Dean R; Queener SF; Shaw MM; Smith JW
Antimicrob Agents Chemother; 1994 Aug; 38(8):1834-7. PubMed ID: 7986016
[TBL] [Abstract][Full Text] [Related]
16. Anti-Pneumocystis carinii activity of PS-15, a new biguanide folate antagonist.
Hughes WT; Jacobus DP; Canfield C; Killmar J
Antimicrob Agents Chemother; 1993 Jul; 37(7):1417-9. PubMed ID: 8363369
[TBL] [Abstract][Full Text] [Related]
17. Current issues in the treatment and prophylaxis of Pneumocystis carinii pneumonia in HIV infection.
Morris-Jones SD; Easterbrook PJ
J Antimicrob Chemother; 1997 Sep; 40(3):315-8. PubMed ID: 9338481
[No Abstract] [Full Text] [Related]
18. Experimental evaluation of combined prophylaxis against murine pneumocystosis and toxoplasmosis.
Brun-Pascaud M; Chau F; Simonpoli AM; Girard PM; Derouin F; Pocidalo JJ
J Infect Dis; 1994 Sep; 170(3):653-8. PubMed ID: 8077724
[TBL] [Abstract][Full Text] [Related]
19. Treatment of experimental Pneumocystis carinii infection by combination of clarithromycin and sulphamethoxazole.
Alder J; Mitten M; Shipkowitz N; Hernandez L; Hui YH; Marsh K; Clement J
J Antimicrob Chemother; 1994 Feb; 33(2):253-63. PubMed ID: 8182006
[TBL] [Abstract][Full Text] [Related]
20. Activity of topoisomerase inhibitors against Pneumocystis carinii in vitro and in an inoculated mouse model.
Fishman JA; Queener SF; Roth RS; Bartlett MS
Antimicrob Agents Chemother; 1993 Jul; 37(7):1543-6. PubMed ID: 8395791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
